Richard H. Lussier Appointed Vice President of Worldwide Sales and Ingrid Choupin Named Managing Director, European Sales and Marketing

LEXINGTON, Mass. – RainDance Technologies Inc., a private company pioneering microdroplet-based technologies for single-molecule and single-cell analysis, today announced that it has expanded its leadership team with the appointments of Richard H. Lussier as Vice President of Worldwide Sales, and Ingrid Choupin as Managing Director of European Sales and Marketing.

As we continue to extend the capabilities of our platform, we are witnessing tremendous opportunity in new applied and geographic markets,” said Roopom Banerjee, President and CEO of RainDance Technologies. “Rich and Ingrid are proven industry leaders who will help the company capitalize on these opportunities by building on our recent international success and forging new customer alliances around the world.”

As VP of Worldwide Sales, Richard Lussier will be responsible for advancing RainDance’s customer relationships and growth into all research and clinical markets that the company serves globally. He brings more than 20 years of industry experience in life science sales and commercial operations. Mr. Lussier joins RainDance from Cell Biosciences where he was the Vice President of Worldwide Sales and Service. His prior experience includes leadership positions building out the field sales, service and support organizations at Solexa (now part of Illumina Inc.), Fluidigm, as well as nearly 15 years in the Applera businesses, Applied Biosystems (now part of Life Technologies) and Celera Genomics. During his tenure at Applied Biosystems, Mr. Lussier served as President and General Manager of the company’s Japanese subsidiary. He holds a B.S. in Biology from Rhode Island College and an M.B.A. from The Fox School of Business at Temple University.

“RainDance is experiencing strong growth in its targeted resequencing and sequence enrichment business,” said Lussier. “I look forward to working with the world-class team at RainDance to help our customers and partners leverage the company’s innovative microdroplet-based solutions to accelerate basic and clinical disease research.”

Ingrid Choupin joins RainDance as Managing Director of European Sales and Marketing. Ms. Choupin brings more than 18 years of sales and strategic marketing experience in life science tools and diagnostics products. She will be responsible for growing RainDance’s commercial business across the European continent. In her most recent position as Associate Director of Global Sales and Strategy Development at Affymetrix, she led the corporate strategy to re-engineer the company’s microarray platform to drive growth in new markets. Prior to joining Affymetrix in 2002, Ms. Choupin served in various sales and management positions at Invitrogen, now part of Life Technologies. Ms. Choupin holds a Masters of Biochemistry from the Université d’Orsay in Paris and a marketing management degree from the Institut Superieur De Gestion, also in Paris. Ms. Choupin will be based outside of Paris, France.

“RainDance is the market leader in targeted resequencing data quality and delivers unparalleled genomic coverage and completeness using microdroplet-based PCR,” said Choupin. “RainDance is well positioned for success not only in research fields, but also in fast-growth markets for medical genetics and diagnostics. I look forward to building a strong team in Europe and adding to a compelling growth story.”

About RainDance Technologies

RainDance Technologies provides novel microdroplet-based solutions that accelerate breakthroughs in disease research, human healthcare and industrial markets. RainDance’s proprietary technology platform delivers exquisite sensitivity and data quality that inspires scientists, researchers and clinicians to rethink the way they design experiments, approach discovery, or conduct clinical care. The core RainStorm™ technology empowers customers to conduct de novo science in an ultra high throughput, simple, flexible, and low cost manner. The company provides resolution of molecular, biological and physiological events from large population samples to unprecedented single cell analysis, all inside a contained droplet microenvironment that enables quantification, single molecule sensitivity, and preserves sample integrity with no bias or contamination. RainDance’s commercial products include instruments and high-value consumables and reagents for targeted resequencing validation and sequence enrichment for next-generation sequencing, ultra-deep sequencing, and methylation analysis. RainDance sells directly in the U.S. and in Europe, and is building distribution networks in Europe and Asia-Pacific. RainDance Technologies, with headquarters in Lexington, MA and a European sales office in the United Kingdom, has approximately 75 employees worldwide.

For more information, please visit www.raindancetech.com.